Provided by Tiger Trade Technology Pte. Ltd.

Arcutis Biotherapeutics Inc.

22.74
+0.91004.17%
Post-market: 22.740.00000.00%19:46 EDT
Volume:821.16K
Turnover:18.66M
Market Cap:2.82B
PE:-179.25
High:23.00
Open:22.03
Low:21.95
Close:21.83
52wk High:31.77
52wk Low:11.86
Shares:124.03M
Float Shares:88.24M
Volume Ratio:0.43
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1269
EPS(LYR):-0.1269
ROE:-9.30%
ROA:-1.95%
PB:14.89
PE(LYR):-179.25

Loading ...

Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2025

Major Issues Report

Form 8-K - Current report